Chapter 4
References
1.
Ishimoto
H,
Nakamura
H,
Miyoshi
T. Epidemiological study on relationship between breast cancer
mortality and dietary factors.
Tokushima J Exp Med. 1994 ;41(3-4):103-14.
2.
Li XM,
Ganmaa D,
Sato A. The experience
of
3.
Sim HG,
Cheng CW.
Changing demography of prostate cancer in
4.
5. Carmody J, Olendzki B, Reed G, Andersen V, Rosenzweig P. A Dietary Intervention for Recurrent Prostate Cancer After Definitive Primary Treatment: Results of a Randomized Pilot Trial. Urology. 2008; 72(6):1324-8.
6.
Ornish
DM,
Lee KL,
Fair WR,
Pettengill EB,
Carroll
PR. Dietary trial in prostate cancer: Early experience and
implications for clinical trial design. Urology. 2001;57(4 Suppl 1):200-1.
7.
Ornish D,
Weidner
G,
Fair WR,
Marlin R,
Pettengill EB,
Raisin
CJ,
Dunn-Emke
S,
Crutchfield L,
Jacobs
FN,
Barnard
RJ,
Aronson
WJ,
McCormac
P,
McKnight
DJ,
Fein JD,
Dnistrian AM,
Weinstein J,
Ngo TH,
Mendell
NR,
Carroll
PR. Intensive lifestyle changes may affect the progression of
prostate cancer. J Urol. 2005;174(3):1065-9.
8.
Bray GA, Popkin BM. Dietary fat
intake does affect obesity: American
Journal of Clinical Nutrition. 68(6):1157-73, 1998
9.
Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out
of apparently conflicting data.
Epidemiol Rev.
2007;29:88-97.
10.
Hebert JR. Barone J.
Reddy MM. Backlund JY.
Natural killer cell activity in a
longitudinal dietary fat intervention trial. Clinical Immunology &
Immunopathology. 1990; 54(1):103-16
11.
Malter M. Schriever G.
components of vegetarian and omnivorous men.
Nutrition & Cancer. 1989;
12(3):271-8
12.
Vujanovic NL.
Basse P.
Herberman RB.
Whiteside TL. Antitumor functions of natural killer cells and control
of metastases. Methods (
13.
Hebert JR. Augustine A.
Barone J. Kabat GC.
Kinne DW. Wynder EL.
Weight, height and body mass index in the prognosis of breast cancer: early
results of a prospective study.
Int J Cancer.
1988; 42(3):315-8
14.
Holm LE. Nordevang E.
Hjalmar ML. Lidbrink E.
Callmer E.
Nilsson B. Treatment failure and dietary habits in women with breast
cancer. Treatment failure and
dietary habits in women with breast cancer.
J Nat Cancer Inst. 1993; 85(1):32-6
15.
Gregorio
DI. Emrich LJ.
Graham S.
Marshall JR.
Nemoto T.
Dietary fat consumption and survival among women
with breast cancer.
J Nat Cancer Inst. 1985 ;
75(1):37-41
16. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P, Hudis C, Butler J, Merkel D, Kristal A, Caan B, Michaelson R, Vinciguerra V, Del Prete S, Winkler M, Hall R, Simon M, Winters BL, Elashoff RM. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006; 98(24):1767-76.
17.
Brown J, Byers T, Thompson K, Eldridge B, Doyle C, Williams AM.
Nutrition during and after cancer treatment: a guide for informed choices
for cancer patients. CA Cancer J Clinic 2001; 51:153-81.
18.
Anon. Eating hints for cancer
patients: before, during and after treatment.
Available at:
http://www.cancer.gov/cancertopics/eatinghints/page7#F6.
Accessed May 4, 2008.
19. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB, Mayer RJ, Nelson H, Whittom R, Hantel A, Thomas J, Fuchs CS. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007 Aug 15;298(7):754-64.
20.
Boone CW. Kelloff GJ.
Freedman LS Intraepithelial
and postinvasive neoplasia as a stochastic continuum of clonal evolution, and
its relationship to mechanisms of
chemopreventive drug action. Journal of Cellular Biochemistry - Supplement.
17G:14
25, 1993
21.
Djuric Z. Kritschevsky D.
Modulation of oxidative DNA damage levels by dietary fat and calories.
Mutation Research. 1993 ;
295(4-6):181-90
22. Verwaerde C, Delanoye A, Macia L, Tailleux A, Wolowczuk I. Influence of high-fat feeding on both naive and antigen-experienced T-cell immune response in DO10.11 mice. Scand J Immunol. 2006 Nov;64(5):457-66.
23. Wallace JM.
Nutritional and botanical modulation of the inflammatory cascade –
eicosanoids, cyclooxygenases, and lipoxygenases – as an adjunct in cancer
therapy. Integr Cancer Ther.
2002; 1(1):7-37.
24. Harris RE, Robertson FM, Abou-Issa HM, Farrar WB, Brueggemeier R.
Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Med Hypotheses. 1999 Apr;52(4):291-2.
25. Dogan S, Hu X, Zhang Y, Maihle NJ, Grande JP, Cleary MP. Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res. 2007;9(6):R91.
26.
Slattery ML, Curtin K, Ma K, Edwards S, Schaffer D,
27. Verwaerde C, Delanoye A, Macia L, Tailleux A, Wolowczuk I. Influence of high-fat feeding on both naive and antigen-experienced T-cell immune response in DO10.11 mice. Scand J Immunol. 2006 Nov;64(5):457-66.
28. Norred WP, Marzuki A. Effects of dietary saturated or polyunsaturated fat on hepatic glutathione S-transferase activity. Drug Nutr Interact. 1984;3(1):11-20.
29.
Djuric Z. Kritschevsky D.
Modulation of oxidative DNA damage levels by dietary fat and calories.
Mutation Research. 1993 ;
295(4-6):181-90
30.
Kesteloot H, Lesaffre E, Joossens JV.
Dairy
fat, saturated animal fat, and cancer risk.
Prev Med. 1991;20(2):226-36
31.
Meyer F, Bairati I, Shadmani R, Fradet Y, Moore L.
Dietary
fat and prostate cancer survival. Cancer Causes Control. 1999;10(4):245-51.
32. Strom SS, Yamamura Y, Forman MR, Pettaway CA, Barrera SL, DiGiovanni J.
Saturated fat intake predicts
biochemical failure after prostatectomy.
Int J Cancer.
2008 Jun 1;122(11):2581-5.
33.
Zhang S. Folsom AR.
Sellers TA. et al.
Better breast cancer
survival for
postmenopausal women who are less overweight and eat less fat. The
Health Study. Cancer. 1995;
76(2):275-83
34.
Jain M. Miller AB.
To T. Premorbid diet and the
prognosis of women with breast
cancer. J Natl Cancer Inst. 1994;
86(18):1390-7
35. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 1997;57(2):253-8.
36. Burns CP. Halabi S. Clamon GH. Hars V. Wagner BA. Hohl RJ. Lester E. Kirshner JJ. Vinciguerra V. Paskett E. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res. 1999;5(12):3942-7
37. Ogilvie GK, Fettman MJ,
Mallinckrodt CH, Walton JA, Hansen RA,
38.
Gutt CN,
Brinkmann L, Mehrabi A, Fonouni H, Müller-Stich BP, Vetter G, Stein JM, Schemmer
P, Büchler MW. Dietary omega-3-polyunsaturated fatty acids prevent
the development of metastases of colon carcinoma in rat liver.
Eur J Nutr.
2007 Aug;46(5):279-85.
39. Baronzio G. Freitas I. Griffini P. Bertone V. Pacini F. Mascaro G. Razzini E. Gramaglia A. Omega-3 fatty acids can improve radioresponse modifying tumor interstitial pressure, blood rheology and membrane peroxidability. Anticancer Res. 1994; 14(3A):1145-54
40. Hardman WE, Avula CP, Fernandes G, Cameron IL. Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res 2001;7(7):2041-9
Hardman WE, Moyer MP, Cameron IL. Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects. Br J Cancer 1999;81(3):440-8
Kimura Y, Takaku T, Nakajima S, Okuda H. Effects of carp and tuna oils on 5-fluorouracil-induced antitumor activity and side effects in sarcoma 180-bearing mice. Lipids 2001 Apr;36(4):353-9
Rudra PK, Krokan HE. Cell-specific enhancement of doxorubicin toxicity in human tumour cells by docosahexaenoic acid. Anticancer Res 2001 Jan-Feb;21(1A):29-38
Dupertuis YM, Meguid MM, Pichard C. Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):427-32.
41.
Simopoulos AP. The Importance of the Omega-6/Omega-3 Fatty Acid Ratio
in Cardiovascular Disease and Other Chronic Diseases. Exp Biol Med (
42. Noguchi M, Rose DP, Earashi M,
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917):860-7.
43. Rose DP. Connolly JM. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer. 37(2):119-27, 2000
44. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 1997;57(2):253-8.
45. Wallace JM.
Nutritional and botanical modulation of the inflammatory cascade –
eicosanoids, cyclooxygenases, and lipoxygenases – as an adjunct in cancer
therapy. Integr Cancer Ther.
2002; 1(1):7-37.
46. Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol. 2005 Mar;16(3):359-71.
47.
Simopoulos AP. The Importance of the Omega-6/Omega-3 Fatty Acid Ratio
in Cardiovascular Disease and Other Chronic Diseases. Exp Biol Med (
48. Rienagel M.
IF rating tables. Available
at:
http://www.inflammationfactor.com/rating_tables.php. Accessed May 8,
2008.
49.
Heasman KZ. Sutherland HJ.
Campbell JA.
Elhakim T.
Boyd NF. Weight gain uring adjuvant chemotherapy for breast cancer.
Breast Cancer Research & Treatment.
1985;5(2):195-200.
50.
Nichols HB, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Holick CN, Egan KM.
Post-diagnosis weight change, body mass index, and breast cancer
survival. Presented at 6th
Annual Conference on Frontiers in Cancer Prevention Research, December 7, 2007.
Abstract B95.
51. Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, Hurwitz P, Hollenbeck A, Leitzmann MF. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer. 2007 Feb 15;109(4):675-84.
Dignam JJ,
Polite BN,
Yothers G,
Raich P,
Colangelo L,
O'Connell MJ,
Wolmark N. Body mass index and outcomes in
patients who receive adjuvant chemotherapy for colon cancer.
J Natl
Cancer Inst. 2006 Nov 15;98(22):1647-54
Soliman PT, Bassett RL Jr, Wilson EB, Boyd-Rogers S, Schmeler KM, Milam MR, Gershenson DM, Lu KH Limited public knowledge of obesity and endometrial cancer risk: what women know. Obstet Gynecol. 2008 Oct;112(4):835-42.
52. Warburg O. The metabolism of
tumors.
Warburg O. On the origin of cancer cells. Science 1956; 123: 309–14.
Krebs Jr., ET Krebs, Sr., ET Beard HH. The unitarian or trophoblastic thesis of cancer. Medical Record 1950; 163: 150–71
53. Santisteban GA. Ely JT. Hamel EE. Read DH. Kozawa SM. Glycemic modulation of tumor tolerance in a mouse model of breast cancer. Biochemical & Biophysical Research Communications. 132(3):1174-9, 1985
54. Mathupala SP.
Rempel A.
Planas M. Porta I. Padro JB. Carbohydrate and lipid metabolism in the cancer. Nutricion Hospitalaria. 1994; 9(2):69-77.
Boyd DB. Insulin and cancer. Integr Cancer Ther. 2003; 2(4):315-29.
55. Jenkins DJ. Josse RG.
Jenkins AL. Wolever
TM. Vuksan V. Implications of
altering the rate of carbohydrate absorption from the gastrointestinal tract.
Clinical & Investigative Medicine - Medecine Clinique et Experimentale.
1995;18(4):296-302.
56.
Gunter MJ,
Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and
candidate genes. J Nutr Biochem.
2006
Mar;17(3):145-56.
57. Komninou D, Ayonote A, Richie JP Jr, Rigas B.
Insulin resistance and its contribution to colon carcinogenesis.
Exp Biol Med (
Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-48
Torizuka T, Tamaki N, Inokuma T, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 1995; 36: 1811-7.
Avril N. Menzel M. Dose J. Schelling M. Weber W. Janicke F. Nathrath W. Schwaiger M. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nuclear Medicine. 42(1):9-16, 2001
58. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002 Jan 1;20(1):42-51.
59. Wyatt CJ. Evaluation of the composition of the regional diet in Sonora, México: incidence of colon cancer. Arch Latinoam Nutr. 1998 Sep;48(3):225-30.
60. Chau CF, Yang P, Yu CM, Yen GC. Investigation on the lipid- and cholesterol-lowering abilities of biocellulose. J Agric Food Chem. 2008 Mar 26;56(6):2291-5.
Sadiq Butt M, Tahir-Nadeem M, Khan MK, Shabir R, Butt MS. Oat: unique among the cereals. Eur J Nutr. 2008 Mar;47(2):68-79.
Wells CL, Barton RG, Jechorek RP, Gillingham KJ, Cerra FB. Effect of fiber supplementation of liquid diet on cecal bacteria and bacterial translocation in mice. Nutrition. 1992 Jul-Aug;8(4):266-71.
Kestell P, Zhao L, Zhu S, Harris PJ, Ferguson LR. Studies on the mechanism of cancer protection by wheat bran: effects on the absorption, metabolism and excretion of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis. 1999 Dec;20(12):2253-60.
61. Nilsson AC, Ostman EM, Holst JJ, Björck IM. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr. 2008 Apr;138(4):732-9.
Weickert MO, Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. 2008 Mar;138(3):439-42.
62. McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer. 2006;55(2):132-40.
63. Norat T. Lukanova A. Ferrari P. Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. International Journal of Cancer. 98(2):241-56, 2002
Alavanja MC. Field RW. Sinha R. Brus CP. Shavers VL. Fisher EL. Curtain J. Lynch CF. Lung cancer risk and red meat consumption among Iowa women. Lung Cancer. 34(1):37-46, 2001
Brown LM. Swanson CA. Gridley G. Swanson GM. Silverman DT. Greenberg RS. Hayes RB. Schoenberg JB. Pottern LM. Schwartz AG. Liff JM. Hoover R. Fraumeni JF Jr. Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States. Cancer Caus Control. 9(5):467-74, 1998
Bosetti C.
La
Vecchia C.
Talamini
R.
Negri E.
Levi F.
Dal Maso
L.
Franceschi S. Food groups and laryngeal cancer risk: a case-control
study from Italy and Switzerland.
Int J Cancer.
100(3):355-60, 2002
De Stefani E.
Ronco A.
Mendilaharsu M.
Guidobono M.
Deneo-Pellegrini H. Meat intake, heterocyclic amines, and risk of
breast cancer: a case-control study in Uruguay.
Cancer Epidem,
Biomarkers Prev. 6(8):573-81, 1997
Chen H. Ward MH. Graubard BI. Heineman EF. Markin RM. Potischman NA. Russell RM. Weisenburger DD. Tucker KL. Dietary patterns and adenocarcinoma of the esophagus and distal stomach. American Journal of Clinical Nutrition. 75(1):137-44, 2002
Howe GR, Burch, JD. Nutrition and pancreatic cancer. Cancer Causes & Control 1996;7: 69–82.
Goodman MT. Hankin JH. Wilkens LR. Lyu LC. McDuffie K. Liu LQ. Kolonel LN. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Research. 57(22):5077-85, 1997
Bosetti C. Negri E. Franceschi S. Pelucchi C. Talamini R. Montella M. Conti E. La Vecchia C. Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer. 93(6):911-5, 2001
Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control 1996; 7: 83–94
64. Hebert JR. Hurley TG. Ma Y. The effect of dietary exposures on recurrence and
mortality in early stage breast cancer. Breast Cancer Res Treat. 1998;51(1):17-28
65. Winterbourn, CC. Superoxide-dependent production of hydroxyl radicals in the presence of iron salts. (Letter). Biochem J. 1982; 205: 463
66. Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis. 1999;20(12):2209-18
Karmali RA. Eicosanoids in neoplasia. Preventive Medicine. 16(4):493-502, 1987
Dargel R. Lipid peroxidation--a common pathogenetic mechanism?. Experimental & Toxicologic Pathology. 44(4):169-81, 1992
67.
Bahl M, Ennis M, Tannock IF, Hux JE, Pritchard KI, Koo J, Godwin PJ.
Serum lipids and outcome of early-stage breast cancer: results of a
prospective cohort study.
Breast Cancer Res Treat. 2005; 94(2):135-44.
Vatten LJ, Foss OP, Kvinssland S.
Overall survival of brest cancer
patients in relation to preclinically determined total serum cholesterol, body
mass index, height and cigarette smoking: a population-based study.
Eur J Cancer 1991; 27(5):641-6.
Tartter PI. Papatestas AE. Ioannovich J. Mulvihill MN. Lesnick G. Aufses AH Jr. Cholesterol and obesity as prognostic factors in breast cancer. Cancer. 1981; 47(9):2222-7.
68. Mehta N. Hordines J. Volpe C. Doerr R. Cohen SA. Cellular effects of hypercholesterolemia in modulation of cancer growth and metastasis: a review of the evidence. Surg Oncol. 6(3):179-85, 1997
69. Leibovici J. Klein O. Wollman Y. Donin N. Mahlin T. Shinitzky M. Cell membrane fluidity and adriamycin retention in a tumor progression model of AKR lymphoma. Biochim Biophys Acta. 1996;1281(2):182-8
70. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, Woods MN. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. New Eng J Med 1982; 307: 1542
Armstrong B, Brown J, Clarke H, et al: Diet and reproductive hormones: A study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst 67: 761-767, 1981
Wu A, Pike M, Stram D: Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91: 529-534, 1999
Sacks FM. Castelli WP. Donner A. Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. New Engl J Med. 292(22):1148-51, 1975
Barnard RJ, Aronson WJ, McCormac P, McKnight DJ,
Fein JD, Dnistrian AM, Weinstein J, Ngo TH, Mendell NR, Carroll PR. Intensive
lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;
174(3):1065-9.
Rock CL, Demark-Wahnefried W. Nutrition and
survival after the diagnosis of breast cancer: a review of the evidence.
J Clin Oncol. 2002;
20(15):3302-16.
71. Khosla P. Sundram K. Effects of dietary fatty acid composition on plasma cholesterol. Prog Lipid Res. 35(2):93-132, 1996
72. Khosla P. Sundram K. Effects of dietary fatty acid composition on plasma cholesterol. Prog Lipid Res. 35(2):93-132, 1996
Puska P, Salonen JT, Nissinen A, Tuomilehto J, Vartiainen E, Korhonen H, et al. Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed). 1983;287:1840-4.
73. Porojnicu AC, Lagunova Z, Robsahn TE, Berg JP, Dahlback A, Moan J. Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat. 2007; 102(3):323-8.
Robsahm TE, Trettli S, Dahlback A and Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 2004;15(2):149-58.
Zhou W, Suk R, Liu G, Park S, Neuberg DS, Wain
JC, Lynch TJ, Giovannucci E, Christiani DC.
Vitamin D is associated with improved survival in early-stage non-small
cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2005;
14(10):2303-9
74.
Chan KC,
Lou PP,
Hargrove
JL. High casein-lactalbumin diet accelerates blood coagulation in
rats. J Nutr.
1993;123(6):1010-6.
Mezzano D, Munoz X, Martinez C, Cuevas A, Panes O, Aranda E, Guasch V, Strobel P, Munoz B, Rodriguez S, Pereira J, Leighton F. Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine. Thromb Haemost. 1999;81(6):913-7.
75. Gannon MC, Nuttall FQ, Krezowski PA, Billington CJ, Parker S. The serum insulin and plasma glucose responses to milk and fruit products in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1986;29(11):784-91.
Lljeberg Elmstagahl H, Bjorck I. Milk as a supplement to mixed meals may elevate postprandial insulnemia Eur J Clin Nutr 2001; 55:994-9
76. Lawlor DA, Ebrahim S, Timpson N, Davey Smith G. “Avoiding milk is associated with a reduced risk of insulin resistance and the metabolic syndrome: findings from the British Women’s Heart and Health Study.” Diabetic Med. 2005; 22(6):808-11.
77. Osterlund P, Ruotsalainen T, Peuhkuri K, Korpela R, Ollus A, Ikonen M, Joensuu H, Elomaa I. Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer. Clin Gastroenterol Hepatol. 2004 Aug;2(8):696-703.
78. Knight EM, Nzelibe G, Criss W. Effect of salicylamide on the growth of a Morris hepatoma in rats fed 8% and 25% casein diets. Drug Nutr Interact. 1983;2(2):87-94.
Hawrylewicz EJ. Huang HH. Liu JM. Dietary protein, enhancement of N-nitrosomethylurea-induced mammary carcinogenesis, and their effect on hormone regulation in rats. Cancer Res. 1986; 46(9):4395-9.
Cohen MD. Bryant M. Copeland EM 3rd. Mahaffey SM. Kao KJ. Baumgartner TG. Wei CI. Sitren HS. Total parenteral nutrition in mice bearing a metastatic carcinoma: tumor growth, metastasis and immunologic parameters. Clin Exp Metastasis. 1986;4(4):245-57.
Mahaffey SM. Copeland EM 3rd. Economides E. Talbert JL. Baumgartner TG. Sitren HS. The effect of energy substrate manipulation on tumor growth and metastasis and intermediary metabolism in the parenterally fed mouse. J Pediatr Surg. 1985;20(6):775-84.
79.
Bounous
G. Whey protein concentrate (WPC) and glutathione modulation in
cancer treatment.
Anticancer Res. 2000 Nov-Dec;20(6C):4785-92.
Xiao R, Carter JA, Linz AL, Ferguson M, Badger TM, Simmen FA. Dietary whey protein lowers serum C-peptide concentration and duodenal SREBP-1c mRNA abundance, and reduces occurrence of duodenal tumors and colon aberrant crypt foci in azoxymethane-treated male rats. J Nutr Biochem. 2006 Sep;17(9):626-34.
80.
Marshall
K. Therapeutic applications of whey protein.
Altern Med Rev. 2004 Jun;9(2):136-56.
81. Gannon MC, Nuttall FQ, Krezowski PA, Billington CJ, Parker S. The serum insulin and plasma glucose responses to milk and fruit products in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1986;29(11):784-91.
82. Hoppe C, Molgaard C, Michaelsen
KF. Cow’s milk and linear growth in
industrialized and developing countries.
Ann Rev Nutr.
2006; 26:131-73.
Hoppe C, Molgaard C, Vaag A, Barkholt V, Michaelsen KF. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr. 2005; 59(3):393-8.
83. Bardócz S, Duguid TJ, Brown DS, Grant G, Pusztai A, White A, Ralph A.
The importance of dietary polyamines in cell regeneration and growth.
Br J Nutr. 1995 Jun;73(6):819-28.
Linsalata M, Russo F. Nutritional factors and polyamine metabolism in colorectal cancer.
Nutrition. 2008 Apr;24(4):382-9.
Cipolla BG, Havouis R, Moulinoux JP. Polyamine contents in current foods: a basis for polyamine reduced diet and a study of its long term observance and tolerance in prostate carcinoma patients. Amino Acids. 2007 Aug;33(2):203-12
84. Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002 Sep;11(9):852-61
Heaney RP, McCarron DA, Dawson-Hughes B, Oparil S, Berga SL, Stern JS, Barr SI, Rosen CJ. Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc. 1999;99(10):1228-33.
Cadogan J, Eastell R, Jones N, Barker ME. Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. BMJ. 1997; 315(7118):1255-60.
85. Outwater JL, Nicholson A, Barnard N. Dairy products and breast cancer: the IGF-I, estrogen, and bGH hypothesis. Med Hypotheses. 1997;48(6):453-61.
86. Crosignani P. Russo A. Tagliabue G. Berrino F. Tobacco and diet as determinants of survival in male laryngeal cancer patients. Int J Cancer. 65(3):308-13, 1996
Freng A. Daae LN. Engeland A. Norum KR. Sander J. Solvoll K. Tretli S. Malignant epithelial tumours in the upper digestive tract: a dietary and socio-medical case-control and survival study. Eur J Clin Nutr. 52(4):271-8, 1998
Chan JM, Giovannucci EL.
Dairy products, calcium, and vitamin D and risk of prostate cancer.
Epidemiol Rev. 23(1):87-92,
2001
87. Feldman D, Skowronski RJ,
Peehl DM. Vitamin D and
prostate cancer. Adv Exp Med Biol.
1995; 375:53-63
Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr. 2001;74(4):549-54.
88.
Anon.
Dietary Supplement Fact Sheet: Calcium. Available at:
http://ods.od.nih.gov/factsheets/calcium.asp#h2.
Accessed May 8, 2008.
89.
Anderson J. Got milk?
Nondairy sources of calcium. Available at:
http://www.ext.colostate.edu/PUBS/columnha/ha0206.html.
Accessed May 8, 2008.
Mangels R.
Calcium in the vegan diet.
Available at:
http://www.vrg.org/nutrition/calcium.htm#table1.
Accessed May 8, 2008.
Anon.
Calcium-rich foods. Available at:
http://www.citracal.com/Calcium/Calcium-Rich-Foods.aspx.
Accessed May 8, 2008.
90. Robien K, Cutler GJ, Lazovich D. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control. 2007 Sep;18(7):775-82.
Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun;85(6):1586-91
Cantor I.
Shedding light on vitamin D and integrative oncology.
Integr Cancer Ther. 2008; 7(2).
In press.
91. Kant AK, Block G. Dietary vitamin B-6 intake and food sources in the US population: NHANES II, 1976-1980. Am J Clin Nutr. 1990 Oct;52(4):707-16.
Blumberg J. Testimony, Public Listening Session, 2004 White House Conference on Aging. Available at: http://www.whcoa.gov/about/policy/meetings/summary/blumbergtestimony.pdf. Accessed May 9, 2008.
92.
Krebs-Smith S, Cook A, Subar A, et al. Fruit and
vegetable intakes of
children and adolescents in the United States.
Arch Pediatr Adolesc Med.1996;
150 :81 –86
93. Sarkar FH, Li Y. Indole-3-carbinol and prostate cancer. J Nutr. 2004 Dec;134(12 Suppl):3493S-3498S
94.
Jacob A,
Wu R, Zhou M, Wang P. Mechanism of the Anti-inflammatory Effect of
Curcumin: PPAR-gamma Activation.
PPAR Res.
2007:8936
95. Stoner GD, Wang LS, Zikri N, Chen T, Hecht SS, Huang C, Sardo C, Lechner JF. Cancer prevention with freeze-dried berries and berry components. Semin Cancer Biol. 2007 Oct;17(5):403-10
96. Karmakar S, Banik NL, Ray SK. Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells. Neurochem Res. 2007 Dec;32(12):2094-102.
97. Wanjek C. Food is medicine in colon cancer fight. Available at: http://www.durhamsbeefarm.com/coloncancer.htm. Accessed May 9, 2008.
98. Hebert JR, Hurley TG. Ma Y. The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Research & Treatment. 1998;51(1):17-28
Rohan TE, Hiller JE, McMichael AJ. Dietary factors and survival from breast cancer. Nutr Cancer 1993;20(2):167-77.
Holmes MD, Hunter DJ, Colditz GA, Stampfer MJ, Hankinson SE, Speizer FE, Rosner B, Willett WC. Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA. 1999; 281(10):914-20.
Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 2002;20(15):3302-16.
Goodman MT, Kolonel LN, Wilkens LR, Yoshizawa CN, Le Marchand L, Hankin JH. Dietary factors in lung cancer prognosis. Eur JCancer 1992;28:495-501.
99. Hwang ES, Bowen PE. Can the consumption of tomatoes or lycopene reduce cancer risk? Integr Cancer Ther. 2002;1(2):121-32.
100.
Kucuk O,
Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood
DP Jr. Effects of lycopene supplementation in patients with localized
prostate cancer. Exp Biol Med (
101. Schroder FH, Roobol MJ, Boeve ER, de Mutsert R, Zuijdgeest-van Leeuwen SD, Kersten I, Wildhagen MF, van Helvoort A. “Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement.” Eur Urol. 2005; 48(6):922-30.
102. Jackson SJ, Singletary KW. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J Nutr. 2004;134(9):2229-36.
103. Munday R, Munday CM. Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds. J Agric Food Chem. 2004 Apr 7;52(7):1867-71.
104. Meng Q, Qi M, Chen DZ, Yuan R, Goldberg ID, Rosen EM, Auborn K, Fan S. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med. 2000;78(3):155-65.
Fowke JH, Longcope C, Hebert JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):773-9.
105. Dong Z. Effects of food factors on signal transduction pathways. Biofactors 2000; 12:17-28.
106. Scholar EM, Wolterman K, Birt DF, Bresnick E. The effect of diets enriched in cabbage and collards on murine pulmonary metastasis. Nutrition & Cancer. 1989;12(2):121-6.
107. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis. 2004 Jan;25(1):83-90.
108. Bell DR, Gochenaur K. Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts. J Appl Physiol. 2006 Apr;100(4):1164-70
109. Wedge DE, Meepagala KM, Magee JB, Smith SH, Huang G, Larcom LL. nticarcinogenic Activity of Strawberry, Blueberry, and Raspberry Extracts to Breast and Cervical Cancer Cells. J Med Food. 2001;4(1):49-51
110. Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK. Anti-angiogenic property of edible berries. Free Radic Res. 2002 Sep;36(9):1023-31.
111.
Marty M,
Pivot X. The potential of anti-vascular endothelial growth factor
therapy in metastatic breast cancer: Clinical experience with anti-angiogenic
agents, focusing on bevacizumab.
Eur J Cancer.
2008 May;44(7):912-20.
112. Reinacher-Schick A, Pohl M, Schmiegel W. Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies. Nat Clin Pract Gastroenterol Hepatol. 2008 May;5(5):250-67.
113. Scambia G. Ranelletti FO. Panici PB. De Vincenzo R. Bonanno G. Ferrandina G. Piantelli M. Bussa S. Rumi C. Cianfriglia M. et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol. 1994;34(6):459-64.
114. Shapiro AB. Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol. 1997;53(4):587-96.
Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Nat Acad Sci. 1998;95(17):9831-6,.
115. Halvorsen BL, Holte K, Myhrstad
MC, Barikmo I, Hvattum E, Remberg SF, Wold AB, Haffner K, Baugerod H, Andersen
LF, Moskaug O, Jacobs DR Jr, Blomhoff R. A Systematic Screening of Total
Antioxidants in Dietary Plants.
J Nutr.
2002;132:461-471.
116. Cao G, Russell RM, Lischner N, Prior RL. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr. 1998 Dec;128(12):2383-90.
117. Asami DK, Hong YJ, Barrett DM, Mitchell AE. Comparison of the total phenolic and ascorbic acid content of freeze-dried and air-dried marionberry, strawberry, and corn grown using conventional, organic, and sustainable agricultural practices. J Agric Food Chem. 2003;51(5):1237-41.
118. Olsson ME, Andersson CS, Oredsson S, Berglund RH, Gustavsson KE. Antioxidant levels and inhibition of cancer cell proliferation in vitro by extracts from organically and conventionally cultivated strawberries. J Agric Food Chem. 2006 Feb 22;54(4):1248-55.
119.
Prior RL. Cao G. Analysis of
botanicals and dietary supplements for antioxidant capacity:
a review. J AOAC Int 2000;
83(4):950-6.
120. Dreizen S, McCredie KB, Keating MJ, Andersson BS. Nutritional deficiencies in patients receiving cancer chemotherapy. Postgrad Med. 1990; 87(1):163-7, 170.
121. Faber M, Coudray C, Hida H, Mousseau M, Favier A. Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study. Biol Trace Element Res. 1995; 47(1-3):117-23
122. Lamm DL, Riggs DR, Shriver JS, vanGilder PF, Rach JF, DeHaven JI. Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol. 1994; 151(1):21-6
123. Takatsuka H, Takemoto Y, Iwata N, Suehiro A, Hamano T, Okamoto T, Kanamaru A, Kakishita E. Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 2001;28(8):769-74
124. Misirlioglu CH, Demirkasimoglu T, Kucukplakci B, Sanri E, Altundag K.
Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer. Med Oncol. 2007;24(3):308-11.
Simone CB 2nd, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med. 2007 Mar-Apr;13(2):40-7
125. Meyer F, Bairati I, Jobin E, Gélinas M, Fortin A, Nabid A, Têtu B. Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients. Nutr Cancer. 2007;59(1):29-35.
McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer. 2006;55(2):132-40.
Nagle CM, Purdie DM, Webb PM, Green A, Harvey PW, Bain CJ. Dietary influences on survival after ovarian cancer. Int J Cancer2003; 106(2):264-9.
126. Sakuta H, Suzuki T, Yasuda H, Wakiyama H, Hase K. Plasma vitamin B12, folate and homocysteine levels in gastrectomized men. Clin Nutr. 2005 Apr;24(2):244-9.
127. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev. 2007 Aug;33(5):407-18.
Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of Antioxidant Supplementation on Chemotherapeutic Toxicity: A Systematic Review of the Evidence from Randomized Controlled Trials. Int J Cancer 2008. Accepted for publication.
128. Simone CB 2nd, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med. 2007 Mar-Apr;13(2):40-7
Shen J, Zhang W, Wu J, Zhu Y. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
Int J Hyperthermia. 2008 Mar;24(2):151-9.
Jüliger S, Goenaga-Infante H, Lister TA, Fitzgibbon J, Joel SP. Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species. Cancer Res. 2007 Nov 15;67(22):10984-92.
Zhang XY, Bai DC, Wu YJ, Li WG, Liu NF. Proanthocyanidin from grape seeds enhances anti-tumor effect of doxorubicin both in vitro and in vivo. Pharmazie. 2005 Jul;60(7):533-8.
129. Losso JN. The biochemical and functional food properties of the bowman-birk inhibitor. Crit Rev Food Sci Nutr. 2008 Jan;48(1):94-118.
130. Cave WT Jr. Omega 3 fatty acid diet effects on tumorigenesis in experimental animals. World Rev Nutr Diet. 1991; 66:462-76
Karmali RA, Adams L, Trout JR. Plant and marine n-3 fatty acids inhibit experimental metastasis of rat mammary adenocarcinoma cells. Prostaglandins Leukot Essent Fatty Acids. 1993; 48(4):309-14
131. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharm 2006;71:1397-1421.
132. Bemis DL, Capodice JL, Anastasiadis AG, Katz AE, Buttyan R. Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression. Nutr Cancer. 2005;52(2):202-12.
McCarty MF, Block KI. Multifocal angiostatic therapy: an update. Integr Cancer Ther. 2005;4(4):301-14.
HemaIswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res. 2006;20(4):239-49;
133. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, Woods MN. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. New Eng J Med 1982; 307: 1542
Armstrong B, Brown J, Clarke H, et al: Diet and reproductive hormones: A study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst 67: 761-767, 1981
Wu A, Pike M, Stram D: Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91: 529-534, 1999
134. Monroe KR, Murphy SP, Henderson BE, Kolonel LN, Stanczyk FZ, Adlercreutz H, Pike MC. Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the Multiethnic Cohort Study. Nutr Cancer. 2007;58(2):127-35.
Rose DP. Dietary fiber and breast cancer. Nutr Cancer. 1990;13(1-2):1-8.
Fowke JH, Longcope C, Hebert JR. Macronutrient intake and estrogen metabolism in healthy postmenopausal women. Breast Cancer Res Treat. 2001 Jan;65(1):1-10.
135.
Weng JR,
Tsai CH, Kulp SK, Chen CS.
Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer
Lett. 2008 Apr 18;262(2):153-63
Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res. 2007 Mar;55(3):224-36.
136. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 1997;17(2):279-86.
137. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharm 2006;71:1397-1421.
Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets. 2005;5(2):117-29.
Singh S, Khar A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem. 2006;6(3):259-70.
Chauhan DP.
Chemotherapeutic potential of curcumin for colorectal cancer.
Curr Pharm Des.
2002;8(19):1695-706
Du B, Jiang L, Xia Q, Zhong L. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy 2006;52(1):23-8
HemaIswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res. 2006;20(4):239-49;
138. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharm 2006;71:1397-1421.
139. Aggarwal BB, Takada Y, Oommen OV. From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Investig Drugs. 2004;13(10):1327-38;